
Accelerate antibody discovery by rapidly identifying high-quality drug candidates.
For pharmaceutical and biotech R&D, AbCellera is a leading AI platform for accelerating antibody discovery. Its AI-powered technology rapidly screens millions of immune cells, drastically shortening discovery timelines and increasing the probability of identifying high-quality drug candidates. This enables research teams to accelerate therapeutic development and improve clinical success rates.
Prices and features are updated regularly but can change at any time — always confirm on the official website. Some links on this page are affiliate links.
Be the first to know when AbCellera drops a new discount, adds features, or changes pricing.



AbCellera accelerates antibody discovery by rapidly screening millions of immune cells to identify high-quality antibody candidates. Its AI-powered platform addresses bottlenecks in early drug development, enabling R&D professionals to find novel therapies faster. This technology is crucial for organizations prioritizing swift clinical progression and improved success rates.
We use cookies to understand how you use Zekai and improve the site. Analytics runs only if you accept. Privacy Policy